Site Search
Professionals 347 results
Capabilities 81 results
Practice Area
Winston’s Intellectual Property (IP) Practice is one of the most active and highly regarded in the United States per Chambers USA, Benchmark Litigation US, and Best Law Firms®, among other ranking organizations. Our team features some of the country’s best IP lawyers, attorneys with the technical abilities to litigate and try highly complex IP disputes, and technical lawyers who provide critical advisory services.
Practice Area
We routinely help clients protect and commercialize their intellectual property (IP) assets and provide due diligence on complex technology and IP transactions. We negotiate and draft IP licenses and transfers; provide strategic guidance on optimal structures for IP and IT transactions; and evaluate copyright, trademark, and patent portfolios and provide related due diligence activities in connection with IPOs, mergers and acquisitions, private equity investments, licenses, and other corporate transactions.
Practice Area
As society and business become even more digitalized, technology and intellectual property (IP) have become key focal points for businesses. Our Technology Antitrust Group combines the cross-practice and cross-office experience of our lawyers to assist clients in successfully navigating the dynamic convergence of technology, antitrust, and IP law. We understand the challenges presented by the ever-changing digital landscape and are committed to providing our clients with tailored solutions to address their specific needs.
Experience 115 results
Experience
|April 2, 2026
Business Combination and Secured Financing of Keo World and Maha Capital AB
Served as legal counsel to KEO World, Inc., a Miami-based fintech platform specializing in embedded credit and B2B digital payments, in connection with its business combination with Maha Capital AB, a publicly listed investment company on Nasdaq Stockholm. The transaction, which closed on April 2, 2026, was structured as a reverse triangular merger through which KEO World became a wholly owned subsidiary of Maha, with KEO World's parent entity receiving approximately 141 million newly issued Maha shares and nearly 49.2 million earn-out warrants as consideration. In connection with the closing, Maha also executed two directed capital raises totaling USD 27 million at SEK 16 per share and announced a planned third raise of USD 8 million ahead of a contemplated dual listing on a U.S. national securities exchange. Based on publicly available disclosures, the combined transaction has been valued at approximately USD 680 million.
Experience
|March 18, 2026
Winston & Strawn LLP Advises Maxim Group LLC on $100 Million IPO of BHAV Acquisition Corp
Winston & Strawn LLP represented the underwriter, Maxim Group LLC, in connection with the $100 million initial public offering of BHAV Acquisition Corp. The offering consisted of 10,000,000 units priced at $10.00 per unit, with each unit comprising one Class A ordinary share and one right. Each right entitles the holder to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of the Company’s initial business combination.
Experience
|March 16, 2026
Winston & Strawn Advises D. Boral Capital on $120 Million IPO of Pono Capital Four, Inc.
Winston & Strawn LLP served as counsel to D. Boral Capital LLC in connection with the $120 million initial public offering of Pono Capital Four, Inc.. The offering was led by D. Boral Capital LLC as sole book-running manager and consisted of 12,000,000 units priced at $10.00 per unit.
Insights & News 1,916 results
In the Media
|April 24, 2026
|1 Min Read
Aimee Fagan Joins Winston in Dallas
Winston & Strawn recently announced that Aimee Fagan has joined the firm’s Dallas office as a partner in the Litigation Department and a member of the Intellectual Property Practice. Aimee is a first-chair trial lawyer whose practice focuses on intellectual property and complex commercial litigation. She represents clients in high-stakes disputes, with significant experience in technology and IP matters, particularly within the energy sector, as well as across the technology, financial services, private equity, medical, and retail industries.
In the Media
|April 24, 2026
|1 Min Read
The American Lawyer Spotlights Winston’s Momentum with Six Partner Additions
Winston was featured in The American Lawyer following the firm’s addition of six lateral partners across Chicago, New York, Washington, D.C., and Dallas in April, further strengthening key practices including leveraged finance, investigations, intellectual property, and appellate litigation.
Recognitions
|April 20, 2026
|Less Than 1 Min Read
Jason Campbell Named to Los Angeles Business Journal’s 2026 Top 100 Lawyers List
Winston partner Jason Campbell was named to the Los Angeles Business Journal’s 2026 Top 100 Lawyers list. This honor recognizes lawyers who not only set the standard for excellence in law but also demonstrate an outstanding commitment to advancing the legal profession and the greater Los Angeles community.
Other Results 58 results
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
Site Content
Location
Since opening in 2011, Winston & Strawn’s Houston office has grown to nearly 60 lawyers and is home to many long-standing leaders of the Houston legal and business communities. Our Houston office hosts a comprehensive transactional team specializing in private equity, capital markets, and public companies, as well as extensive commercial litigation and intellectual property practices—with nearly all Houston IP attorneys possessing technical degrees. We are also home to a leading energy and infrastructure group that focuses on oil and gas projects and infrastructure litigation, and an international arbitration practice. Our robust offerings demonstrate our commitment to the continued growth of the city’s global, economic, and cultural footprint.